Class II recall: Lexia LLC: Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB
The FDA reported a Class II recall of Broadway Joe's Pain Cream, a topical product containing CBD isolate, hempseed oil, and histamine dihydrochloride, distributed in 4 oz jars under NDC 83088-8120-6. The recall was initiated due to current good manufacturing practice (CGMP) deviations, specifically potential contamination of the raw material used in the product.
Most relevant for: Patients who have purchased or used Broadway Joe's Pain Cream (CBD isolate, 3000 mg) for topical pain relief.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More pain management updates
- Network meta-analysis ranks opioid options for breakthrough cancer painOct 13, 2026
- PEG scale cut-off of 6 identifies high-impact pain in adolescentsOct 1, 2026
- Perspective proposes random-point acupuncture as improved sham controlOct 1, 2026
- Exercise reduces pain and improves function in pregnancy-related pelvic girdle painOct 1, 2026
- Triple-agonist retatrutide cuts weight, knee pain, sleep apnea eventsSep 29, 2026